Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Randomized Phase II Study of Induction Chemotherapy Followed by Gemcitabine or Capecitabine Based Chemoradiotherapy for Locally Advanced Non-Metastatic Pancreatic Cancer

NCT01032057 is registered in ClinicalTrials.gov with Lisette Nixon as lead sponsor.

NCT NCT01032057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Randomized Phase II Study of Induction Chemotherapy Followed by Gemcitabine or Capecitabine Based Chemoradiotherapy for Locally Advanced Non-Metastatic Pancreatic Cancer
Lead sponsor
Lisette Nixon
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
June 30, 2013
Enrollment
114 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer